Advanced glycation end products for preoperative frailty screening in older cardiac surgery patients
- PMID: 37021973
- DOI: 10.1111/jgs.18361
Advanced glycation end products for preoperative frailty screening in older cardiac surgery patients
Abstract
Background: Advanced glycation end products (AGEs) are potential biomarkers of biological age. Skin Auto Fluorescence (SAF) can assess AGEs non-invasively. We evaluated the association of SAF levels with frailty and its predictive ability for adverse outcomes in older cardiac surgery patients.
Methods: This was a retrospective analysis of prospectively acquired data from a two-center observational cohort study. We measured SAF level in cardiac surgery patients aged ≥70. Primary outcome was preoperative frailty. A comprehensive frailty assessment was performed before surgery based on 11 individual tests assessing the physical, mental, and social domain. Frailty was defined as at least 1 positive test in each domain. Secondary outcome measures were severe postoperative complications and a composite endpoint of 1-year disability (defined by WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) questionnaire) or mortality.
Results: Among 555 enrolled patients, 122 (22%) were frail. SAF level was most strongly associated with dependent living status (aRR 2.45 (95% CI 1.28-4.66)) and impaired cognition (aRR 1.61 (95% CI 1.10-2.34)). A decision algorithm to identify frail patients including SAF level, sex, prescription drugs, preoperative hemoglobin, and EuroSCORE II resulted in a C-statistic of 0.72 (95% CI 0.67-0.77). SAF level was also associated with disability or death after 1 year (aRR 1.38 (95% CI 1.06-1.80)). The aRR for severe complications was 1.28 (95% CI 0.87-1.88).
Conclusions: Higher SAF level is associated with frailty in older cardiac surgery patients, as well as an increased risk of death or disability. This biomarker could potentially optimize preoperative risk stratification for cardiac surgery.
Keywords: advanced glycation end products; aging; cardiac surgery; frailty; preoperative risk assessment.
© 2023 The American Geriatrics Society.
References
REFERENCES
-
- Pierri MD, Capestro F, Zingaro C, Torracca L. The changing face of cardiac surgery patients: an insight into a Mediterranean region. Eur J Cardio-Thoracic Surg. 2010;38:407-413. doi:10.1016/j.ejcts.2010.02.040
-
- Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus Statement. The frailty operative definition-consensus conference project. J Gerontol Ser A. 2013;68(1):62-67. doi:10.1093/gerona/gls119
-
- Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol. 2017;70(6):689-700. doi:10.1016/j.jacc.2017.06.024
-
- Knittel JG, Wildes TS. Preoperative assessment of geriatric patients. Anesthesiol Clin. 2016;34(1):171-183. doi:10.1016/j.anclin.2015.10.013
-
- Afilalo J, Eisenberg MJ, Morin J-F, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56(20):1668-1676. doi:10.1016/j.jacc.2010.06.039
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical